6505--Rituximab Biosimilars (VA-20-00048624)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79720R0045
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center seeks pricing for Rituximab 500mg vials or biosimilar versions through a solicitation. One award will be made for the aggregate of either the reference product line items or one of the biosimilar options for the base year through four option years, with estimated annual quantities of 26,793 vials. Offerors must provide unit prices for all years and list a unique 11-digit NDC number for each drug offered, with prices to include a 0.5% Cost Recovery Fee and not exceed two decimal places. Proposals are due June 16, 2020.
There is no set-aside designation. The main NAICS code is 325412 with PSC code 6505. Successful offerors will supply the drugs to multiple Department of Veterans Affairs and Department of Defense prime vendor contractors for distribution to government facilities nationwide. Estimated total contract value including options is between $50-75 million.
Notice text
Rituximab
One award will be made in the aggregate for line items:
1a and 1b, or 2a and 2b, or 3a and 3b.
To be considered for award, offerors must submit a price for the base year and all four one-year options for all line items. 1a and 1b, or 2a and 2b, or 3a and 3b.
Prices offered shall not exceed two decimal places. Offered prices must include the Cost Recovery Fee of 0.5%, as outlined in Scope of Contract. Offerors must list an 11 digit NDC number for each offered drug that is unique to the Offeror's company as outlined in scope of contract. If the offeror is a distributor, the NDC number must be unique to the distributor.
Files
| File | Type | Posted |
|---|---|---|
| 36E79720R0045 0001.docx | DOCX document | |
| 36E79720R0045.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Rituximab Biosimilars (VA-20-00048624) Effective 9/15/2020-09/14/2021 | Award Notice | |
| This notice | Solicitation | |
| 6505--Rituximab Biosimilars (VA-20-00048624) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity